CHENGDU HUASUN TECHNOLOGY GROUP INC. , LTD.

Chengdu huasun technology group Inc. , LTD.

000790

CNE0000001H5

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 05/07/2024 am IST			5-day change	1st Jan Change
3.54 ^CNY	+2.61%		+2.31%	-30.04%

30/05	Chengdu huasun technology group Inc. , LTD. Approves 2023 Profit Distribution Plan	CI
03/05	Huasun Technology to Cancel 3.8 Million Repurchased Shares	MT

Chengdu Taihe Health Technology Group Inc Ltd Appoints Hu Yuanyang as New President of the Company

May 09, 2017 at 04:00 pm IST

Chengdu Taihe Health Technology Group Inc. Ltd. has announced that it has appointed Hu Yuanyang as new president of the company.

Latest news about Chengdu huasun technology group Inc. , LTD.

Chengdu huasun technology group Inc. , LTD. Approves 2023 Profit Distribution Plan	31/05	CI
Huasun Technology to Cancel 3.8 Million Repurchased Shares	03/05	MT
Chengdu Huasun Technology Group Inc. , Ltd. Announces Cash Profit Distribution Proposal for 2023	30/04	CI
Chengdu huasun technology group Inc. , LTD. Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04	CI
Chengdu huasun technology group Inc. , LTD. Reports Earnings Results for the Full Year Ended December 31, 2023	29/04	CI
Chengdu Huasun Technology to Construct Drug Ingredient Plant for 480 Million Yuan	07/11	MT
Chengdu huasun technology group Inc. , LTD. Reports Earnings Results for the Nine Months Ended September 30, 2023	30/23/30	CI
Chengdu huasun technology group Inc. , LTD. Reports Earnings Results for the Half Year Ended June 30, 2023	29/23/29	CI
Chengdu Huasun Technology to Buy 51% of Local Peer for 51 Million Yuan; Shares Jump 3%	08/23/08	MT
Chengdu huasun technology group Inc. , LTD. singed a Share Transfer Agreement to acquire a 51% stake in Tibet Kangyu Pharmaceutical Co., Ltd. from Tibet Wan?an Drug Information Consulting Co., Ltd. for CNY 51 million.	08/23/08	CI
Chengdu Huasun Technology Group Inc. , Ltd. Elects Chen Xudong and Zhu Chaoxi as Independent Directors; and Zhu Ying as Non-Employee Supervisor	29/23/29	CI
Chengdu huasun technology group Inc. , LTD. agreed to acquire Sichuan Bohaoda Biotechnology Co., Ltd. from Sichuan Yuanhong Biotechnology Co., Ltd. and Chengdu Bohaoda Biotechnology Co., Ltd for CNY 1 billion.	21/23/21	CI
Chengdu huasun technology group Inc. , LTD. announced that it expects to receive funding from Chengdu Yuanhong Biological Technology Co., Ltd., and other investors	20/23/20	CI
Chengdu Huasun Technology Group Inc. , Ltd. Announces Final Dividend on Share A for 2022, Payable on June 13, 2023	08/23/08	CI
Chengdu huasun technology group Inc. , LTD. Approves Profit Distribution Proposal for 2022	25/23/25	CI
Chengdu huasun technology group Inc. , LTD. Reports Earnings Results for the First Quarter Ended March 31, 2023	27/23/27	CI
Chengdu Huasun Technology Group Inc., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	27/22/27	CI
Chengdu Huasun Technology to Invest $28 Million in Pharmaceutical Firm	30/22/30	MT
Chengdu Huasun Technology Group Inc., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	30/22/30	CI
Chengdu Huasun Technology Group Inc., Ltd. Announces Final Cash Dividend on A Shares for 2021, Payable on July 14, 2022	07/22/07	CI
Chengdu Huasun Technology Group Inc., Ltd. Approves Cash Dividend for the Year 2021	26/22/26	CI
Chengdu Huasun Technology Group Inc., Ltd. announced that it expects to receive CNY 399.999998 million in funding from Chengdu Yuanhong Biological Technology Co., Ltd.	20/22/20	CI
Chengdu Huasun Technology Group Inc., Ltd. Announces Profit Distribution Proposal for 2021	06/22/06	CI
Chengdu Huasun Technology Group Inc., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	29/22/29	CI
Chengdu Huasun Technology Group Inc., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	29/22/29	CI

Chart Chengdu huasun technology group Inc. , LTD.

Duration

Period

Chart Chengdu huasun technology group Inc. , LTD.

More charts

Chengdu Huasun Technology Group Co Ltd, formerly Chengdu Taihe Health Technology Group Inc., Ltd., is principally engaged in manufacture and distribution of Chinese medicines and Western medicines, fabrication and installation services of steel structures, as well as production and sale of bio-engineering products. The Company primarily provides Chinese medicines, Western medicines, biological drugs, veterinary drugs and veterinary biological vaccines, as well as modern steel structures. Its pharmaceutical products include oral liquid, capsules, biological products and veterinary drugs, among others. The Company operates its businesses primarily in the China domestic market, with Sichuan province as its main market.

Sector

Pharmaceuticals

Calendar

20/08/2024 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
CHENGDU HUASUN TECHNOLOGY GROUP INC. , LTD.	-30.04%	31Cr
ELI LILLY AND COMPANY	+56.89%	82TCr
NOVO NORDISK A/S	+39.52%	63TCr
JOHNSON & JOHNSON	-6.55%	35TCr
MERCK & CO., INC.	+15.99%	32TCr
ABBVIE INC.	+7.92%	30TCr
ASTRAZENECA PLC	+13.74%	24TCr
NOVARTIS AG	+13.83%	22TCr
ROCHE HOLDING AG	-0.49%	22TCr
AMGEN INC.	+7.94%	17TCr